Skip to main content
Log in

Predictors of Outcome in Pediatric Anaplastic Large Cell Lymphoma

  • Research Paper
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Objective

To determine the event-free survival (EFS), overall survival (OS) and predictors of outcome in pediatric anaplastic large cell lymphoma treated with a uniform protocol.

Method

This hospital record review was done between June, 2016 to March, 2019 and data was extracted from January, 2003 to May, 2016 for anaplastic large cell lymphoma (ALCL) in patients aged 1 to 18 years (n=27). EFS and OS were calculated by the Kaplan Meier method. Cox proportional model and the Cox regression model were used for univariate analysis and multivariate analysis respectively.

Results

EFS and OS at three years was 70.4% (CI: 0.49–0.84) and 77.2% (CI: 0.56 −0.89), respectively. On univariate analysis stage III and IV, hemoglobin less than 10 g/dL and presence of pleural effusion predicted lower survival. On multivariate analysis, pleural effusion was a significant predictor of low EFS and OS.

Conclusion

Pleural effusion is a potential clinical marker of poor outcome among children with anaplastic large cell lymphoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms. Blood. 2016;127: 2375–90.

    Article  CAS  Google Scholar 

  2. Burkhardt B, Zimmermann M, Oschlies I, Niggli F, Mann G, Parwaresch R, et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol. 2005;131: 39–49.

    Article  Google Scholar 

  3. Lowe EJ, Sposto R, Perkins SL, Gross TG, Finlay J, Zwick D, et al. Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: Final results of Children’s Cancer Group Study 5941. Pediatr Blood Cancer. 2009;52: 335–9.

    Article  Google Scholar 

  4. Seidemann K, Tiemann M, Schrappe M, Yakisan E, Simonitsch I, Janka-Schaub G, et al. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood. 2001;97: 3699–706.

    Article  CAS  Google Scholar 

  5. Rosolen A, Pillon M, Garaventa A, Burnelli R, d’Amore ES, Giuliano M, et al. Anaplastic large cell lymphoma treated with a leukemia-like therapy: report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92 protocol. Cancer. 2005;104: 2133–40.

    Article  CAS  Google Scholar 

  6. Gambacorti-Passerini C, Messa C, Pogliani EM. Crizotinib in anaplastic large-cell lymphoma. N Engl J Med. 2011; 364:775–6.

    Article  Google Scholar 

  7. Mossé YP, Lim MS, Voss SD, Wilner K, Ruffner K, Laliberte J, et al. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: A Children’s Oncology Group phase 1 consortium study. Lancet Oncol. 2013;14: 472–80.

    Article  Google Scholar 

  8. Murphy SB, Fairclough DL, Hutchison RE, Berard CW. Non-Hodgkin’s lymphomas of childhood: An analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol. 1989;7: 186–93.

    Article  CAS  Google Scholar 

  9. Lakshmaiah KC, Guruprasad B, Shah A, Kavitha S, Abraham LJ, et al. Anaplastic large cell lymphoma: A single institution experience from India. J Cancer Res Ther. 2013;9: 649–52.

    Article  CAS  Google Scholar 

  10. Link MP, Shuster JJ, Donaldson SS, Berard CW, Murphy SB. Treatment of children and young adults with early-stage non-hodgkin’s lymphoma. N Engl J Med. 1997;337: 1259–66.

    Article  CAS  Google Scholar 

  11. Reiter A, Schrappe M, Tiemann M, Ludwig WD, Yakisan E, Zimmermann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood. 1999;94: 3294–306.

    CAS  PubMed  Google Scholar 

  12. Damm-Welk C, Pillon M, Woessmann W, Mussolin L. Prognostic factors in paediatric anaplastic large cell lymphoma: Role of ALK. Front Biosci Sch Ed. 2015;7: 205–16.

    Article  Google Scholar 

  13. Pillon M, Gregucci F, Lombardi A, Santoro N, Piglione M, Sala A, et al. Results of AIEOP LNH-97 protocol for the treatment of anaplastic large cell lymphoma of childhood. Pediatr Blood Cancer. 2012;59: 828–33.

    Article  Google Scholar 

  14. Alexander S, Kraveka JM, Weitzman S, Lowe E, Smith L, Lynch JC, et al. Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: A report from the Children’s Oncology Group. Pediatr Blood Cancer. 2014; 61:2236–42.

    Article  CAS  Google Scholar 

  15. Ceppi F, Ortiz R, Antillón F, Vasquez R, Gomez W, Gamboa J, et al. Anaplastic large cell lymphoma in Central America: A report from the Central American Association of Pediatric Hematology Oncology (AHOPCA): Treatment of ALCL: A Report From a LMIC. Pediatr Blood Cancer. 2016;63: 78–82.

    Article  CAS  Google Scholar 

  16. Resham S, Khan R, Ashraf S, Rizvi A, Altaf S. Clinical features and treatment outcomes of children with anaplastic large cell lymphoma in Pakistan: A multicenter study. J Pediatr Hematol Oncol. 2019;41: 5.

    Article  Google Scholar 

  17. Arya LS, Dinand V, Thavaraj V, Bakhshi S, Dawar R, Rath GK, et al. Hodgkin’s disease in Indian children: outcome with chemotherapy alone. Pediatr Blood Cancer. 2006;46: 26–34.

    Article  Google Scholar 

  18. Lowe EJ, Gross TG. Anaplastic large cell lymphoma in children and adolescents. Pediatr Hematol Oncol. 2013;30: 509–19.

    Article  CAS  Google Scholar 

  19. Le Deley M-C, Reiter A, Williams D, Delsol G, Oschlies I, McCarthy K, et al. Prognostic factors in childhood anaplastic large cell lymphoma: Results of a large European intergroup study. Blood. 2008;111: 1560–6.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

AP: designed the research study, analysed the data, drafted the paper; DP: analyzed the data and drafted the paper; MCS,ST: acquisition and interpretation of the data for the paper, drafted the paper; SB: conception and designed the research study, analyzed the data, drafted the paper. All authors contributed to the drafting of the work, finally approved the work and agreed to be accountable for integrity of the data.

Corresponding author

Correspondence to Sameer Bakhshi.

Ethics declarations

Institutional Ethics Committee of AIIMS, Delhi; No. IESC/T-331, June 23, 2015.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patel, A., Pushpam, D., Sharma, M. et al. Predictors of Outcome in Pediatric Anaplastic Large Cell Lymphoma. Indian Pediatr 57, 523–526 (2020). https://doi.org/10.1007/s13312-020-1849-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-020-1849-z

Keywords

Navigation